Headquarters
USA

Moderna

Moderna is a pioneering messenger in RNA therapeutics, an entirely new in-vivo drug modality that produces human proteins or antibodies inside patient cells that are, in turn, secreted or active intracellularly. This breakthrough platform addresses currently undruggable targets and offers a superior alternative to existing drug modalities for a wide range of disease conditions. Founded in late 2010 by Flagship VentureLabs, Cambridge-based Moderna is privately held and currently has strategic agreements with AstraZeneca and Alexion Pharmaceuticals.

访问 Moderna 网站

影响力故事

播客

来自贡献者 Moderna

关于我们

  • 我们的任务
  • 我们的历史
  • 领导团队
  • 影响力

加入我们

快捷链接

语言版本

隐私政策和服务条款

站点地图

© 2025 世界经济论坛